Related Experiment Video
Updated: Aug 9, 2026
09:27
DNA Microarrays: Sample Quality Control, Array Hybridization and Scanning
Published on: March 15, 2011
DNA microarrays in clinical oncology
Sridhar Ramaswamy1, Todd R Golub
1Department of Adult Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston 02115, USA.
Summary
Aberrant gene expression drives cancer. DNA microarrays offer a global view of cancer gene expression, aiding in the discovery of diagnostic and therapeutic markers for clinical oncology.
Area of Science:
- Oncology
- Genomics
- Molecular Biology
Background:
- Aberrant gene expression is fundamental to tumor initiation and progression.
- A comprehensive understanding of all aberrantly expressed genes in human cancer remains incomplete.
Purpose of the Study:
- To review the clinical applications of DNA microarrays for analyzing human cancer gene expression.
- To discuss recent studies utilizing expression profiling.
- To identify future research directions and the impact of expression profiling on clinical oncology.
Main Methods:
- Review of clinical applications of DNA microarrays.
- Discussion of recent studies in cancer gene expression profiling.
- Identification of research avenues and clinical impact.
Main Results:
- DNA microarrays provide global views of human cancer gene expression.
- Expression profiling can identify potential genetic markers for diagnosis and therapy.
- The field of expression profiling is emerging with significant potential for clinical oncology.
Conclusions:
- Expression profiling using DNA microarrays is a powerful tool in cancer research.
- This technology promises to advance cancer diagnosis, therapy, and our understanding of the disease.
- Further research is needed to fully realize the clinical impact of gene expression profiling.
